ZEAL

Zealand Pharma A/S American Depositary Shares

Delisted

ZEAL was delisted on the 29th of September, 2022.

11 hedge funds and large institutions have $10.4M invested in Zealand Pharma A/S American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Goldman Sachs
1
Goldman Sachs
New York
$6.52M +$6.52M +500,916 New
Bank of America
2
Bank of America
North Carolina
$2.87M -$11K -846 -0.4%
AIC
3
AWM Investment Company
New York
$631K -$74K -5,743 -10%
Jane Street
4
Jane Street
New York
$312K +$3.41K +262 +1%
Morgan Stanley
5
Morgan Stanley
New York
$87K +$2.6K +200 +3%
US Bancorp
6
US Bancorp
Minnesota
$7K
BlackRock
7
BlackRock
New York
$6K
UBS Group
8
UBS Group
Switzerland
$4K -$6.22K -546 -61%
CS
9
Credit Suisse
Switzerland
$4K +$4K +285 New
Wells Fargo
10
Wells Fargo
California
$1K
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$1K
FCM
12
Farallon Capital Management
California
-$7.75M -496,890 Closed